RISK FACTORS FOR OUTCOMES OF PATIENTS WITH HISTOLOGICALLY PROVEN CHECKPOINT-INHIBITOR COLITIS

被引：0
|
作者：
Voth, Elida
Saha, Srishti
Raffals, Laura
Pardi, Darrell
Khanna, Sahil
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S49 / S50
页数：2
相关论文
共 50 条
  • [1] RISK FACTORS FOR OUTCOMES OF PATIENTS WITH HISTOLOGICALLY PROVEN CHECKPOINT-INHIBITOR COLITIS
    Voth, Elida
    Saha, Srishti
    Raffals, Laura
    Pardi, Darrell
    Khanna, Sahil
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S36 - S37
  • [2] MANAGEMENT OF PATIENTS WITH HISTOLOGICALLY PROVEN CHECKPOINT-INHIBITOR COLITIS
    Voth, Elida
    Saha, Srishti
    Raffals, Laura H.
    Pardi, Darrell S.
    Khanna, Sahil
    GASTROENTEROLOGY, 2020, 158 (06) : S1165 - S1165
  • [3] A Retrospective Study of Treatment Options for Checkpoint-Inhibitor Colitis and Their Impact on Disease Outcomes
    Satila, Malek
    Rivera, Andres
    Abdul-Baki, Kian
    Lu, Linfeng
    Takigawa, Kei
    Cruz, Carolina Colli
    Menon, Raakhi
    Baerman, Elliot Axel
    Sullivan, Andrew
    Gupta, Tanvi
    Salim, Hamza
    Vemulapalli, Varun
    Lee, Irene J.
    Khan, Ayesha
    Natha, Cristina M.
    Varatharajalu, Krishnavathana
    Coleman, Garrett T.
    Zhao, Dan
    Thomas, Anusha
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S) : S905 - S906
  • [4] Extracorporeal Photopheresis for Colitis Induced by Checkpoint-Inhibitor Therapy
    Apostolova, Petya
    Becher, Burkhard
    Zeiser, Robert
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (03) : 294 - 296
  • [5] Treatment of Checkpoint-inhibitor Induced Colitis Leading to Worsening of Melanoma
    Pasha, Syed Bilal
    Tahan, Veysel
    Hilli, Jaffar
    Yezaz, Ghouri
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1153 - S1153
  • [6] Gastrointestinal Infection Prior to Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk for Checkpoint-Inhibitor Colitis
    Shatila, Malek
    Abdul-Baki, Kian
    Rivera, Andres
    Takigawa, Kei
    Lee, Irene J.
    Sullivan, Andrew
    Gupta, Tanvi
    Lu, Linfeng
    Menon, Raakhi
    Khan, Ayesha
    Salim, Hamza
    Baerman, Elliot Axel.
    Cruz, Carolina Colli
    Natha, Cristina M.
    Vemulapalli, Varun
    Coleman, Garrett T.
    Varatharajalu, Krishnavathana
    Zhou, Yan
    Zhang, Hao Chi
    Shafi, Mehnaz A.
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S) : S823 - S824
  • [7] Outcomes of patients with histologically proven acute acalculous cholecystitis
    Nikfarjam, Mehrdad
    Manya, Kiran
    Fink, Michael A.
    Hadj, Andrew K.
    Muralidharan, Vijayaragavan
    Starkey, Graham
    Jones, Robert M.
    Christophi, Christopher
    ANZ JOURNAL OF SURGERY, 2012, 82 (12) : 918 - 922
  • [8] Incidence and risk factors of immune checkpoint inhibitor-induced colitis in Korean patients with cancer
    Kim, Tae Kyun
    Lee, Hyun Seok
    Kim, Eun Soo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2025, 40 (01) : 49 - 56
  • [9] Evaluation of psychosocial factors concerning the management of side effects of oncological patients undergoing checkpoint-inhibitor immunotherapy
    Strauch, N.
    Missalla, I.
    Goerling, U.
    Mieville, H.
    Keller, U.
    Letsch, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 117 - 117
  • [10] Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer-A multicenter observational analysis
    Frost, Nikolaj
    Unger, Kristina
    Blum, Torsten Gerriet
    Misch, Daniel
    Kurz, Sylke
    Laeders, Heike
    Olive, Elisabeth
    Raspe, Matthias
    Hilbrandt, Moritz
    Koch, Myriam
    Bohmer, Dirk
    Senger, Carolin
    Witzenrath, Martin
    Grohe, Christian
    Bauer, Torsten
    Modest, Dominik P.
    Kollmeier, Jens
    LUNG CANCER, 2023, 179
12345